MedTrace Logo

Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters

NCT01357408 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2013-01-07

No results posted yet for this study

Summary

The purpose of the Heart Failure and Risk of re-Admissions Determined by Abnormal REVEAL Parameters (HF RADAR) study is to evaluate the ability of cardiac rhythm (Cardiac Compass) data to predict future cardiac events in heart failure (HF) patients recently discharged after a hospitalization for heart failure who have or plan to have a implanted loop recorder (ILR), specifically, the Reveal XT device. The study will enroll 40 HF patients (with LV function ≥ 40%) admitted to an acute care facility (observation status or hospital stay) for heart failure who either have a Reveal XT device in place or plan to have the ILR device inserted for clinical indication within 14 days of discharge from the hospitalization. HF patients will be followed for 6 months. Device date will be captured during normal clinic visits and at 6 months.

Conditions

Sponsors & Collaborators

  • Central Bucks Specialists, Ltd.

    collaborator OTHER

  • Drexel University

    collaborator OTHER

  • The Valley Hospital

    collaborator UNKNOWN

  • Saint Thomas Research Institute, LLC

    collaborator OTHER

  • Thomas Jefferson University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01357408 on ClinicalTrials.gov